Search clinical trials for: Nerve growth factors
Total 168066 results
-
Karyopharm Therapeutics IncWithdrawn
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; National Cancer Institute (NCI); Multiple Myeloma Research...Active, not recruitingRecurrent Primary AmyloidosisUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Iovance Biotherapeutics, Inc.; Prometheus Inc.CompletedSkin Cancer | Melanoma (Skin)United States
-
Poitiers University HospitalSanofi; Celgene; Amgen; Intergroupe Francophone du MyelomeActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryFrance
-
Rush University Medical CenterTerminatedBrain and Central Nervous System TumorsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Nervous System Lymphoma | Recurrent Primary Vitreoretinal DLBCL | Refractory Nervous System Lymphoma | Refractory Primary Vitreoretinal DLBCLUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron PharmaceuticalsCompletedUveal MelanomaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
University College, LondonCancer Research UK; CelgeneActive, not recruitingPlasmacytomaUnited Kingdom
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cells Non-Hodgkin LymphomaItaly
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
-
Attaya SuvannasankhaJanssen Scientific Affairs, LLC; Indiana Institute for Medical ResearchWithdrawnMultiple MyelomaUnited States
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
Second Affiliated Hospital, School of Medicine,...CompletedPrimary Central Nervous System LymphomaChina
-
AmgenTerminated
-
CelgeneCompletedMultiple Myeloma | Renal ImpairmentUnited States, Canada
-
Bristol-Myers SquibbAbbVie; CelgeneCompletedMultiple MyelomaUnited States, Germany, Italy, Greece, Netherlands, Australia, Spain, Poland, Canada, France, Japan
-
University of Michigan Rogel Cancer CenterTerminatedGlioma | High Grade Glioma | Pontine TumorsUnited States
-
Roswell Park Cancer InstituteCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom
-
TakedaCompleted
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNorway, Denmark, Netherlands, Czechia, Australia, Turkey, Spain, Belgium, Switzerland, France, Greece, Italy, Poland
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
Fondazione Italiana Linfomi ONLUSActive, not recruiting
-
PETHEMA FoundationActive, not recruitingNewly Diagnosed Multiple MyelomaSpain
-
PETHEMA FoundationCelgene Corporation; AmgenActive, not recruitingSmoldering Multiple MyelomaSpain
-
Samsung Medical CenterActive, not recruitingMultiple MyelomaKorea, Republic of
-
Poitiers University HospitalSanofi; Intergroupe Francophone du MyelomeActive, not recruiting
-
National Cancer Institute (NCI)CompletedLocally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine TumorUnited States, Canada
-
Criterium, Inc.Celgene Corporation; AmgenTerminated
-
PETHEMA FoundationCelgene Corporation; Array BioPharmaCompleted
-
Ciusss de L'Est de l'Île de MontréalCelgene; C3i Center Inc.Active, not recruitingMultiple Myeloma | Relapsed Hematologic MalignancyCanada
-
National Cancer Institute (NCI)NRG OncologyCompletedGlioblastoma | Gliosarcoma | Recurrent Glioblastoma | Oligodendroglioma | Giant Cell Glioblastoma | Recurrent Brain NeoplasmUnited States, Canada
-
Swiss Group for Clinical Cancer ResearchTerminatedMultiple MyelomaSwitzerland, Italy
-
CelgeneCompleted
-
AmgenCompletedCOVID-19United States, Russian Federation, Mexico, Brazil, South Africa, Argentina, Chile, Ukraine
-
Bristol-Myers SquibbAbbVieCompleted
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCWithdrawnRecurrent Plasma Cell MyelomaUnited States
-
AmgenCompletedPsoriatic ArthritisUnited Kingdom, Belgium, United States, Canada, Australia, Taiwan, Czechia, Russian Federation, Hungary, Poland, Korea, Republic of, Italy, New Zealand, France, Bulgaria, Estonia, Romania, Lithuania
-
Bristol-Myers SquibbAbbVieCompletedLymphoma | Multiple MyelomaUnited States, Belgium, France, Germany, Italy, Japan, United Kingdom, Australia, Poland, Puerto Rico, Canada, Denmark, Hungary, Israel, Spain, Czechia, Ireland, Austria, Switzerland, Greece, Turkey, Romania, United Arab Emirates
-
University of LeedsCelgene; Myeloma UKActive, not recruitingMultiple MyelomaUnited Kingdom
-
Epitopoietic Research CorporationUniversity of California, IrvineActive, not recruitingGlioblastoma | GliosarcomaUnited States
-
Virginia Commonwealth UniversityWithdrawnPeriodontitis Chronic Generalized Moderate | Periodontitis Chronic Generalized SevereUnited States
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNetherlands, Belgium, Germany, Spain, Czechia, Greece, Italy, Denmark, Serbia, Turkey
-
Margarida Magalhaes-SilvermanNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Primary Systemic Amyloidosis | Light Chain Deposition Disease | Extramedullary Plasmacytoma | Isolated Plasmacytoma of BoneUnited States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Recurrent Childhood Brain Stem Glioma | Recurrent Childhood Visual Pathway GliomaUnited States
-
Sumitomo Pharma Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
Bulent Ecevit UniversityCompletedGingival Recession | Growth Factors, Combined Defect ofTurkey